Medicare Enrolled
Dr. Savitha Balaraman, MD
Medical Oncology · Madison Heights, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Balaraman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Balaraman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Balaraman
Dr. Savitha Balaraman is a medical oncology specialist in Madison Heights, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Balaraman performed 126,028 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Balaraman received a total of $8,496 from 46 pharmaceutical and/or device companies across 202 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Balaraman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 4% volume in MI
$8,496 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗126,028
Medicare services
Top 4% in MI for medical oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
27,000 | $1 | $4 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
15,900 | $0 | $1 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
14,790 | $0 | $2 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
13,100 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 13,000 | $43 | $166 |
| Paclitaxel chemotherapy injection | 7,336 | $0 | $1 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,750 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
6,190 | $6 | $24 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,471 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 3,360 | $18 | $72 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
2,986 | $36 | $137 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,860 | $1 | $4 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,575 | $8 | $23 |
| Basic blood chemical test (calcium, ionized) A blood test that measures basic chemical levels, specifically including calcium and ionized calcium. |
1,391 | $13 | $41 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
717 | $69 | $265 |
| Injection, leucovorin calcium, per 50 mg | 670 | $3 | $13 |
| Injection, granisetron hydrochloride, 100 mcg | 520 | $0 | $2 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
499 | $23 | $96 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
438 | $40 | $113 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
418 | $2 | $8 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
405 | $103 | $443 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
356 | $11 | $42 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
342 | $2 | $8 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
336 | $85 | $328 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
313 | $12 | $51 |
| Pegfilgrastim-jmdb injection An injection of pegfilgrastim-jmdb, a biosimilar medication. The dose specified is 0.5 mg. |
276 | $90 | $367 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
179 | $100 | $376 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
164 | $64 | $206 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
160 | $51 | $221 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
149 | $51 | $214 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
142 | $1 | $4 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
97 | $1 | $6 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
88 | $23 | $94 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
86 | $41 | $166 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
81 | $16 | $66 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 64 | $119 | $522 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
62 | $26 | $98 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
57 | $106 | $392 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
57 | $138 | $576 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
52 | $144 | $528 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
51 | $2 | $8 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
50 | $96 | $294 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
48 | $44 | $185 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
47 | $20 | $87 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
46 | $124 | $470 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
44 | $16 | $63 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
38 | $26 | $107 |
| New patient office visit, complex (60-74 min) | 38 | $174 | $648 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
34 | $10 | $42 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
27 | $15 | $59 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
26 | $30 | $123 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
22 | $68 | $292 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
22 | $43 | $166 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $82 | $326 |
| Total bilirubin level test A blood test that measures the total amount of bilirubin, a waste product from the breakdown of red blood cells, in your body. |
18 | $5 | $30 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
17 | $4 | $12 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
16 | $5 | $15 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
14 | $7 | $7 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
12 | $72 | $210 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
36.7% high complexity
59.2% medium
4.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,496
Total received (2018-2024)
Avg $1,214/year across 7 years
Top 27% in MI for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
202
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$90
2023
$3,572
2022
$907
2021
$674
2020
$1,742
2019
$637
2018
$874
Payments by company (2024)
Janssen Biotech, Inc.
$90
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme LLC
$2,854
Immunomedics, Inc.
$1,575
PFIZER INC.
$427
Amgen Inc.
$322
Astellas Pharma US Inc
$322
Janssen Biotech, Inc.
$289
Novartis Pharmaceuticals Corporation
$232
Seagen Inc.
$222
Genentech USA, Inc.
$173
AstraZeneca Pharmaceuticals LP
$164
Gilead Sciences, Inc.
$156
AVEO Pharmaceuticals, Inc.
$145
Foundation Medicine, Inc.
$142
Focal Therapeutics, Inc.
$129
Exelixis Inc.
$122
Lilly USA, LLC
$115
Mirati Therapeutics, Inc.
$85
SANOFI-AVENTIS U.S. LLC
$65
Nestle HealthCare Nutrition Inc.
$65
MEDIVATION FIELD SOLUTIONS LLC
$63
Merck Sharp & Dohme Corporation
$62
EMD Serono, Inc.
$62
Regeneron Healthcare Solutions, Inc.
$54
AMAG Pharmaceuticals, Inc.
$52
GENZYME CORPORATION
$50
PharmaEssentia USA Corporation
$47
Pharmacyclics LLC, An AbbVie Company
$41
Alexion Pharmaceuticals, Inc.
$38
Blueprint Medicines Corporation
$37
Celgene Corporation
$34
Ipsen Biopharmaceuticals, Inc
$34
MorphoSys, US Inc.
$32
Aveo Pharmaceuticals, Inc.
$31
ARRAY BIOPHARMA INC
$31
Kite Pharma, Inc.
$26
Pharmacyclics LLC, an AbbVie Company
$24
Karyopharm Therapeutics Inc.
$22
E.R. Squibb & Sons, L.L.C.
$22
TAIHO ONCOLOGY, INC.
$22
Bayer HealthCare Pharmaceuticals Inc.
$20
Grifols USA, LLC
$19
Daiichi Sankyo Inc.
$17
Rigel Pharmaceuticals, Inc.
$17
Myovant Sciences Inc.
$14
INSYS Therapeutics Inc
$12
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 57.2% of all-time payments
Associated products mentioned in payments ›
AFINITOR · AYVAKIT · Alecensa · BESREMI · BOSULIF · BRAFTOVI · Bavencio · BioZorb · Blincyto · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · ELIQUIS · ERLEADA · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · GAVRETO · Gamunex-C · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · MONJUVI · MYLOTARG · Nplate · OCREVUS · OPDIVO · ORGOVYX · PADCEV · Padcev · Perjeta · REBLOZYL · RYBREVANT · Rezlidhia · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNDROS · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TRODELVY · TUKYSA · Tecentriq · Trodelvy · Vectibix · Venclexta · XGEVA · XPOVIO · XTANDI · Xospata · Xtandi · ZENPEP · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
33
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
THE BEHAVIORAL CENTER OF MICHIGAN
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Balaraman is a mixed practice specialist, with above-average Medicare volume (top 4% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Balaraman experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Balaraman performed 27,000 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Balaraman receive payments from pharmaceutical companies?
Yes. Dr. Balaraman received a total of $8,496 from 46 companies across 202 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Balaraman's costs compare to other medical oncologists in Madison Heights?
Dr. Balaraman's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Balaraman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Madison Heights
Browse medical oncologists in Madison Heights ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in MI
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in MI
Which MI medical oncologists receive the most from drug and device companies.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
Immunomedics, Inc. Payments to Doctors
See all physicians who received payments from Immunomedics, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology